Atorvastatin
A2581111
Approved small_molecule completed
Quick answer
Atorvastatin for Dyslipidemias is a Approved program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Dyslipidemias
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed